CRYSTAL GASKINS: Open Payments
NPI 1932601416 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 78 payments from 18 companies in 2025. Trend: 2023 $1,516 · 2024 $1,193 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $234 |
| ABBVIE INC. | 11 | $191 |
| Lilly USA, LLC | 12 | $148 |
| Phathom Pharmaceuticals, Inc. | 8 | $72 |
| Amgen Inc. | 4 | $60 |
| Inspire Medical Systems, Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Exact Sciences Corporation | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
Products named: VRAYLAR, Ozempic, MOUNJARO, VOQUEZNA, KISUNLA, JARDIANCE, INSPIRE, CAPLYTA.
Industry payments across AL — which companies pay providers there.
